keyword
MENU ▼
Read by QxMD icon Read
search

prothrombosis

keyword
https://www.readbyqxmd.com/read/26357866/potential-effects-of-vildagliptin-on-biomarkers-associated-with-prothrombosis-in-diabetes-mellitus
#1
COMPARATIVE STUDY
Sana Khan, Saba Khan, Bibhu Prasad Panda, Mohd Akhtar, Abul Kalam Najmi
OBJECTIVE: Diabetes mellitus (DM) is one of the risks linked with susceptibility of thrombosis. We tried to inspect the effect of a novel oral antidiabetic agent, vildagliptin, in preventing prothrombosis associated with DM. RESEARCH DESIGN AND METHODS: DM was produced by a dose of streptozotocin (STZ) or in albino wistar rats. Rats were treated orally with pioglitazone, standard treatment and vildagliptin alone and in combination for 3 weeks. Finally, the varied levels of coagulation biomarkers, including activated partial thromboplastin time (aPTT), prothrombin time (PT) and fibrinogen and inflammatory parameters, nitric oxide (NO), C-reactive protein (CRP) and TNF-α and lipid profile were estimated along with platelet count and total leukocyte count (TLC)...
2015: Expert Opinion on Therapeutic Targets
https://www.readbyqxmd.com/read/23942473/update-on-raloxifene-mechanism-of-action-clinical-efficacy-adverse-effects-and-contraindications
#2
REVIEW
Salvatore Gizzo, Carlo Saccardi, Tito Silvio Patrelli, Roberto Berretta, Giampiero Capobianco, Stefania Di Gangi, Antonio Vacilotto, Anna Bertocco, Marco Noventa, Emanuele Ancona, Donato D'Antona, Giovanni Battista Nardelli
Raloxifene is the only selective estrogen receptor modulator approved for long-term treatment in the prevention of osteoporotic fractures and for the reduction of invasive breast cancer risk in post-menopausal women. The demonstrated beneficial effects on bone and mammalian tissue led clinical and molecular research to focus mainly on these organs, giving less attention to all other systemic effects. The aim of this review was to evaluate all described systemic effects of raloxifene, investigating its molecular and tissutal mechanism of action...
June 2013: Obstetrical & Gynecological Survey
https://www.readbyqxmd.com/read/23094144/flaxseed-lignan-complex-administration-in-older-human-type-2-diabetics-manages-central-obesity-and-prothrombosis-an-invitation-to-further-investigation-into-polypharmacy-reduction
#3
D E Barre, K A Mizier-Barre, E Stelmach, J Hobson, O Griscti, A Rudiuk, D Muthuthevar
Aim. Animal and human study evidence supports the hypothesis that flaxseed lignan complex (FLC) at a dose of 600 mg secoisolariciresinol diglucoside (SDG)/day for three months would combat hyperglycaemia, dyslipidemia, blood pressure, central obesity, prothrombotic state, inflammation, and low density lipoprotein (LDL) oxidation. Methods. Sixteen type 2 diabetic patients completed this double-blind, randomised crossover placebo-controlled study. A univariate repeated measures analysis of covariance (significance P < 0...
2012: Journal of Nutrition and Metabolism
https://www.readbyqxmd.com/read/20960552/a-personalized-approach-to-metabolic-aspects-of-obesity
#4
REVIEW
Stephen A Brietzke
Metabolic syndrome, which is entwined in semantic controversy as to its actual existence as a distinct entity, links several important health conditions with obesity, and more specifically, excessive visceral adiposity. The most common linked disease states include type 2 diabetes mellitus, hypertension, dyslipidemia, obstructive sleep apnea, and cardiovascular and coronary heart disease. Much of the controversy surrounding the metabolic syndrome case definition is the purported centrality of insulin resistance as root cause, there being no universally agreed-upon standard for measurement of insulin resistance...
September 2010: Mount Sinai Journal of Medicine, New York
https://www.readbyqxmd.com/read/20699256/inflammatory-and-prothrombotic-activation-with-conserved-endothelial-function-in-patients-with-chronic-asymptomatic-chagas-disease
#5
Ramón N Herrera, Elba I Díaz de Amaya, Rossana C Pérez Aguilar, Claudio Joo Turoni, Rodrigo Marañón, Sofía G Berman, Héctor L Luciardi, Alfredo Coviello, María Peral de Bruno
UNLABELLED: Previously, our group showed a prothrombotic state in asymptomatic patients with chronic Chagas disease. The current paper studies the inflammatory status and endothelial function in these patients. METHODS: In 40 patients and 40 healthy volunteers, we evaluated prothrombotic state, blood parasitemia (molecular biology: polymerized chain reaction [PCR]-amplification), tissue factor pathway inhibitor antibodies (aTFPI), interleukin 6 (IL-6), and vascular cell adhesion molecule-1 (VCAM-1)...
October 2011: Clinical and Applied Thrombosis/hemostasis
https://www.readbyqxmd.com/read/20622544/fructose-exercise-and-health
#6
REVIEW
Richard J Johnson, Robert Murray
The large daily energy intake common among athletes can be associated with a large daily intake of fructose, a simple sugar that has been linked to metabolic disorders. Fructose commonly is found in foods and beverages as a natural component (e.g., in fruits) or as an added ingredient (as sucrose or high fructose corn syrup [HFCS]). A growing body of research suggests that excessive intake of fructose (e.g., >50 g.d(-1)) may be linked to development of the metabolic syndrome (obesity, dyslipidemia, hypertension, insulin resistance, proinflammatory state, prothrombosis)...
July 2010: Current Sports Medicine Reports
https://www.readbyqxmd.com/read/20061420/obesity-without-established-comorbidities-of-the-metabolic-syndrome-is-associated-with-a-proinflammatory-and-prothrombotic-state-even-before-the-onset-of-puberty-in-children
#7
Nelly Mauras, Charles Delgiorno, Craig Kollman, Keisha Bird, Melissa Morgan, Shawn Sweeten, Prabhakaran Balagopal, Ligeia Damaso
BACKGROUND: Metabolic syndrome (MS)-related comorbidities in obesity, such as hypertension, dyslipidemia, and glucose intolerance, are increasingly recognized in children, predisposing them to early cardiovascular disease. OBJECTIVE: The objective of the study was to investigate whether markers of inflammation and prothrombosis are abnormal in obese children without established MS comorbidities across puberty, as compared with lean, age-matched controls. SUBJECTS AND METHODS: Obese children (body mass index >95%) with normal fasting glucose, blood pressure, cholesterol and triglycerides were recruited; lean controls (body mass index 10-75%) had no first-degree relatives with MS...
March 2010: Journal of Clinical Endocrinology and Metabolism
https://www.readbyqxmd.com/read/17187150/-treatment-of-neovascular-age-related-macular-degeneration-with-antiangiogenic-drugs
#8
REVIEW
Eduardo Büchele Rodrigues, Eglas Emanuel Rossi, Astor Grumann Junior, Carsten H Meyer, Allen C Ho
Age-related macular degeneration (ARMD) remains a leading cause of blindness in the western world. Several clinical forms of the disease are recognized, whereas choroidal neovascularization (CNV) represents an important manifestation suitable for treatment. The treatment of CNV has been a major focus of research in the past decades, and the first evidence-based established therapy was laser photocoagulation, which reduces the risk of visual loss in extrafoveal lesions. In the late 90's photodynamic therapy has been established as an efficient method for the treatment of predominantly classic and occult CNV...
September 2006: Arquivos Brasileiros de Oftalmologia
https://www.readbyqxmd.com/read/16945051/statin-withdrawal-clinical-implications-and-molecular-mechanisms
#9
REVIEW
Luigi X Cubeddu, Matthew J Seamon
Retrospective analyses of data from the Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM), the National Registry of Myocardial Infarction 4, and the Global Registry of Acute Coronary Events (GRACE) trials revealed that the benefits of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) on acute coronary outcomes are rapidly lost and outcomes worsened if statins are discontinued during a patient's hospitalization for an acute coronary syndrome. Withdrawal of statin therapy in the first 24 hours of hospitalization for non-ST-elevation myocardial infarction increased the hospital morbidity and mortality rate versus continued therapy (11...
September 2006: Pharmacotherapy
https://www.readbyqxmd.com/read/15787345/hypercoagulability-risk-factors-in-children-with-minimal-change-disease-and-the-protective-role-of-protein-c-activity
#10
Neşe Ozkayin, Sevgi Mir, Kaan Kavakli
It is believed that thrombotic activity in nephrotic syndrome is due to an imbalance between procoagulant/thrombotic and anticoagulant/antithrombotic factors in plasma. The aim of this study was to investigate the hypercoagulability risk in childhood minimal change disease and to find possible protective mechanisms with respect to hemostasis. Twenty-six children with minimal change disease were enrolled in this study. All patients were evaluated during an attack and on remission. The control group consisted of 33 healthy children...
2004: International Urology and Nephrology
https://www.readbyqxmd.com/read/15121031/insights-from-apob-from-better-diagnosis-therapy-to-the-medusa-hypothesis
#11
REVIEW
Allan Sniderman, Ken Williams, Steve Haffner, Naveed Sattar
This article will review six of the most important insights that have come from the measurement of apolipoprotein B (apoB). Amongst these are critical clinical advances, which include better definition of those at high risk of vascular disease and better definition of the adequacy of statin therapy. There are also major advances in our understanding of the fundamental processes that interact to cause vascular disease. These include a more precise understanding of the determinants of lipoprotein levels and lipoprotein composition in plasma and, even more importantly, an appreciation of the pivotal role excess fatty acid intake and impaired fatty acid trapping by adipose tissue play in the generation of the complex risk profile that is so common in patients with coronary disease...
May 2004: Atherosclerosis. Supplements
https://www.readbyqxmd.com/read/11689201/is-the-fatty-meal-a-trigger-for-acute-coronary-syndromes
#12
REVIEW
R A Anderson, C J Jones, J Goodfellow
This hypothesis paper aims to illustrate the role of fatty meal ingestion has on the vascular endothelium and coagulation system. In particular highlighting the potential risk of fatty meal ingestion both as a trigger to an adverse factor in patients with acute coronary syndromes. We propose that as a result of ingesting fatty meals as a part of daily living, there occurs a constellation of changes in the vasculature that results in both a hypercoagulable and a provasoconstrictor state. These acute changes in response to a fatty meal on endothelial function, prothrombosis, and platelet activation can potentially trigger, facilitate and propagate the forces that drive acute coronary syndromes...
November 2001: Atherosclerosis
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"